RCUS Operating Cash Flow (Statement)
Arcus Biosciences Inc · Operating Cash Flow (Statement)
RCUS Operating Cash Flow (Statement)
Latest reported-$474.00Mperiod ending
RCUS TTM Cash from Operations (-$25.06M → -$474.00M)
TTM operating cash flow (statement)
High-resolution chart · PNG
RCUS operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -474,000,000 | |
| -488,000,000 | |
| -482,000,000 | |
| -462,000,000 | |
| -339,000,000 | |
| -300,000,000 | |
| -170,000,000 | |
| -158,000,000 | |
| -247,000,000 | |
| -210,000,000 | |
| -306,000,000 | |
| -287,739,000 | |
| -305,739,000 | |
| -313,739,000 | |
| 438,261,000 | |
| 445,897,000 | |
| 473,140,000 | |
| 464,145,000 | |
| -256,171,000 | |
| -243,948,000 | |
| 26,074,000 | |
| 76,131,000 | |
| 111,170,000 | |
| 151,579,000 | |
| -92,085,000 | |
| -87,900,000 | |
| -73,462,000 | |
| -71,098,000 | |
| -55,464,000 | |
| -46,588,000 | |
| -42,996,000 | |
| -20,302,000 | |
| -32,771,000 | |
| -28,709,000 | |
| -25,059,000 |